Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
boston top stories
clinical trials
3
×
deals
fda
life sciences
national blog main
national top stories
roche
3
×
investing
san francisco blog main
san francisco top stories
alexion pharmaceuticals
alnylam pharmaceuticals
avapritinib
biofourmis
biovotion
blueprint medicines
boehringer ingelheim
chugai pharmaceutical
cstone pharmaceuticals
dicerna pharamceuticals
edbi
eli lilly
european medicines agency
fisogatinib
flatiron health
gaido health
genentech
hepatitis b
hepatitis b virus
hepatocellular carcinoma
hereditary transthyretin amyloidosis
jeff albers
kuldeep singh rajput
massmutual ventures
medical devices
medullary thyroid cancer
What
drug
medicines
roche
team
analytics
approval
biofourmis
blueprint
cancer
candidate
caught
causing
currently
data
devices
dicerna
digital
disease
employs
eye
fda
gene
globally
hauls
help
hepatitis
intended
marketing
million
muscle
pact
patients
pay
pharma
pharmaceuticals
producing
protein
raised
regulatory
research
Language
unset
Current search:
boston
×
roche
×
" clinical trials "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug